Abstract
Current prognostication of gastrointestinal stromal tumours is validated on/applies to resected tumours, mainly because surgery is recommended whenever possible. However, pre-treatment prognostication is increasingly warranted, considering the follow-up strategy recently admitted for expectedly low-risk tumours and the possible distinctive molecular features/spontaneous regression of some small cases.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 291-295 |
| Numero di pagine | 5 |
| Rivista | Digestive and Liver Disease |
| Volume | 47 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Biopsy
- Gastrointestinal stromal tumour
- Prognosis
- Proliferation
Fingerprint
Entra nei temi di ricerca di 'Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver